| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 06/02/2005 | WO2005049598A1 Colouring hydrosoluble yellow preparation derived from dihydrochalcones |
| 06/02/2005 | WO2005049597A1 Liquid cyclohexane-tricarboxycylic acid anhydride |
| 06/02/2005 | WO2005049596A1 A process for the preparation of high purity escitalopram |
| 06/02/2005 | WO2005049595A1 Method for the preparation of citalopram |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049562A2 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof |
| 06/02/2005 | WO2005028445A3 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 06/02/2005 | US20050119499 Cyclic hemiacetal derivative and use thereof |
| 06/02/2005 | US20050119495 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation |
| 06/02/2005 | US20050119494 Catalytically hydrogenating C4-dicarboxylic acids and/or derivatives thereof in the gas phase in the presence of copper catalysts and reacting gama-butyrolactone with ammonia or primary amines to give pyrrolidones |
| 06/02/2005 | US20050119416 Ring-opening or closing metathesis reaction of olefin; reduction of carbonyl compound, catalysis, complexing; cyclization, reduction |
| 06/02/2005 | US20050119336 Synthesis of derivatives of ginkgolide C |
| 06/02/2005 | US20050119329 Tetronic and tetramic acids |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119256 Aromatic amino acid derivates and medicinal compositions |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs |
| 06/02/2005 | CA2543155A1 Method for the preparation of citalopram |
| 06/01/2005 | EP1535919A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 06/01/2005 | EP1535917A1 2-oxabicyclo 3.3.0 octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol |
| 06/01/2005 | EP1535916A1 Clathrates of butylphtualide with cyclodextrin or its derivatives,a process for their preparations and the use there of |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534716A1 Heterobicyclic pyrazole derivatives as kinase inhibitors |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534664A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 06/01/2005 | EP1534661A1 Spirobifluorene derivatives, their preparation and uses thereof |
| 06/01/2005 | EP1534660A1 Ketocampholenic acid derivatives and their use in fragrance and flavor applications |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534654A1 Method for the separation of intermediates which may be used for the preparation of escitalopram |
| 06/01/2005 | EP1534276A2 Non-nucleoside reverse transcriptase inhibitors |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1534264A2 Compounds that modulate the activity of ptp-1b and tc-ptp |
| 06/01/2005 | EP1534263A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 06/01/2005 | EP1534259A2 Sulfonamides as potassium channel blockers |
| 06/01/2005 | EP1461315A4 Catalytic carbonylation of three and four membered heterocycles |
| 06/01/2005 | EP1444218B1 Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran |
| 06/01/2005 | EP1404660B1 Process for the production of ethers, typically thf |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1222159B1 Intermediates for making a benzofuran or benzothiophene derivative nitrated in position 5 and uses thereof |
| 06/01/2005 | EP1131061B1 Agent for lowering prolactin |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | EP0993441B1 INHIBITORS OF p38 |
| 06/01/2005 | EP0946499B1 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/01/2005 | EP0944310B8 Stabilized ascorbyl compositions |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1204144C Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2005 | CN1204133C 3-(1-hydroxy-amylene)-5-nitro-3H-benzfuran-2-one, its prepn. method and use |
| 06/01/2005 | CN1204132C Method for preparing L-ascorbic acid |
| 06/01/2005 | CN1204131C Process for the preparation of alpha-methylene lactones |
| 06/01/2005 | CN1204130C Process for preparing optical purity tetrahydrofuran-2-aminic acid |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/26/2005 | WO2005047275A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 05/26/2005 | WO2005047274A1 Preparation of escitalopram |
| 05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 05/26/2005 | WO2005046829A2 Separation of ginkgolides and bilobalide from g. biloba |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046599A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 05/26/2005 | WO2005002582A3 Trp-p8 active compounds and therapeutic treatment methods |
| 05/26/2005 | US20050113596 Nitrating a 2-(2-formylphenoxy) or 2-(2-formylphenylsulfido) alkyl ester or alkoic acid in the presence of sulfuric acid |
| 05/26/2005 | US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/26/2005 | US20050113566 Inhibitors of C-FMS kinase |
| 05/26/2005 | US20050113538 (Meth)acrylate, raw material alcohol for the (meth)acrylate, method of producing the (meth)acrylate and the alcohol, polymer produced by polymerizing the (meth)acrylate, chemically amplified resist composition, and method of the formation of a pattern |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113372 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | CA2543629A1 2-phenyl-benzofuran derivatives, method for the production thereof and their use |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/25/2005 | EP1533294A1 Beta-alanine derivative and use thereof |
| 05/25/2005 | EP1532130A1 Process for the production of an immunosuppressant |
| 05/25/2005 | EP1532129A1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532127A1 PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL |
| 05/25/2005 | EP1532126A2 Method for producing tetrahydrofuran |
| 05/25/2005 | EP1532108A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/25/2005 | EP1532105A1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 05/25/2005 | EP1461329B1 Preparation of substituted phthalic anhydrides and substituted phthalimides |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | EP1185492B1 Acid-catalysed reactions |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | EP0946511B1 Novel compounds with analgesic effect |
| 05/25/2005 | EP0907652B1 Immunosuppressive compounds and methods |
| 05/25/2005 | DE10352082A1 Hexylcarboxanilide Hexylcarboxanilides |
| 05/25/2005 | DE10352067A1 Isopentylcarboxanilide Isopentylcarboxanilide |
| 05/25/2005 | DE10349502A1 1,3-Dimethylbutylcarboxanilide 1,3-Dimethylbutylcarboxanilide |
| 05/25/2005 | CN1620447A Isochroman compounds for treatment of cns disorders |
| 05/25/2005 | CN1620446A Retinol derivatives and cosmestics composition containing the same |
| 05/25/2005 | CN1620445A Catalyst and process for the oxidation of hydrocarbons |
| 05/25/2005 | CN1620429A Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 05/25/2005 | CN1620417A Method for producing phthalic anhydride |